Vascular alterations among young adults with SARS-CoV-2.


Journal

American journal of physiology. Heart and circulatory physiology
ISSN: 1522-1539
Titre abrégé: Am J Physiol Heart Circ Physiol
Pays: United States
ID NLM: 100901228

Informations de publication

Date de publication:
01 01 2021
Historique:
pubmed: 12 12 2020
medline: 23 1 2021
entrez: 11 12 2020
Statut: ppublish

Résumé

While SARS-CoV-2 primarily affects the lungs, the virus may be inflicting detriments to the cardiovascular system, both directly through angiotensin-converting enzyme 2 receptor and initiating systemic inflammation. Persistent systemic inflammation may be provoking vascular dysfunction, an early indication of cardiovascular disease risk. To establish the potential effects of SARS-CoV-2 on the systemic vasculature in the arms and legs, we performed a cross-sectional analysis of young healthy adults (control: 5 M/15 F, 23.0 ± 1.3 y, 167 ± 9 cm, 63.0 ± 7.4 kg) and young adults who, 3-4 wk prior to testing, had tested positive for SARS-CoV-2 (SARS-CoV-2: 4 M/7 F, 20.2 ± 1.1 y, 172 ± 12 cm, 69.5 ± 12.4 kg) (means ± SD). Using Doppler ultrasound, brachial artery flow-mediated dilation (FMD) in the arm and single passive limb movement (sPLM) in the leg were assessed as markers of vascular function. Carotid-femoral pulse wave velocity (PWVcf) was asvsessed as a marker of arterial stiffness. FMD was lower in the SARS-CoV-2 group (2.71 ± 1.21%) compared with the control group (8.81 ± 2.96%) (

Identifiants

pubmed: 33306450
doi: 10.1152/ajpheart.00897.2020
pmc: PMC8083172
doi:

Substances chimiques

ACE2 protein, human EC 3.4.17.23
Angiotensin-Converting Enzyme 2 EC 3.4.17.23

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

H404-H410

Subventions

Organisme : Appalachian State University
ID : COVID-19 Cluster Award
Pays : International

Commentaires et corrections

Type : CommentIn

Références

Circ Res. 2011 May 27;108(11):1358-66
pubmed: 21493895
J Appl Physiol (1985). 1996 Oct;81(4):1807-14
pubmed: 8904603
Hypertension. 2010 May;55(5):1075-85
pubmed: 20351340
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Cardiovasc Res. 2020 Dec 1;116(14):2177-2184
pubmed: 32750108
J Physiol. 2012 Mar 15;590(6):1413-25
pubmed: 22310310
Arterioscler Thromb Vasc Biol. 2007 Oct;27(10):2113-9
pubmed: 17717291
Circulation. 1995 Mar 1;91(5):1314-9
pubmed: 7867167
Circ Res. 2013 Sep 27;113(8):1023-32
pubmed: 23940309
J Am Coll Cardiol. 2010 Mar 30;55(13):1318-27
pubmed: 20338492
Front Immunol. 2014 May 27;5:253
pubmed: 24904596
Semin Immunopathol. 2017 Jul;39(5):529-539
pubmed: 28466096
Circulation. 2005 May 24;111(20):2605-10
pubmed: 15897343
Circulation. 2020 May 19;141(20):1648-1655
pubmed: 32200663
Cytokine Growth Factor Rev. 2020 Jun;53:25-32
pubmed: 32446778
Int J Cardiovasc Imaging. 2010 Aug;26(6):631-40
pubmed: 20339920
Catheter Cardiovasc Interv. 2020 Aug;96(2):336-345
pubmed: 32311816
Hypertension. 2019 Jul;74(1):208-215
pubmed: 31055952
Lancet. 2020 May 2;395(10234):1417-1418
pubmed: 32325026
Circ Res. 1998 Nov 2;83(9):960-5
pubmed: 9797346
J Vasc Surg. 1990 May;11(5):688-94
pubmed: 2186185
Lancet. 1992 Nov 7;340(8828):1111-5
pubmed: 1359209
Scand J Immunol. 2020 Aug;92(2):e12895
pubmed: 32445403
Circulation. 2009 Aug 11;120(6):502-9
pubmed: 19635967
Trends Cardiovasc Med. 2021 Jan;31(1):1-5
pubmed: 33068723
Cell. 2020 May 14;181(4):905-913.e7
pubmed: 32333836
Eur Heart J. 2006 Nov;27(21):2588-605
pubmed: 17000623
J Appl Physiol (1985). 2017 Dec 1;123(6):1708-1720
pubmed: 28883048
N Engl J Med. 2020 May 14;382(20):e60
pubmed: 32343504

Auteurs

Stephen M Ratchford (SM)

Department of Health & Exercise Science, Appalachian State University, Boone, North Carolina.

Jonathon L Stickford (JL)

Department of Health & Exercise Science, Appalachian State University, Boone, North Carolina.

Valesha M Province (VM)

Department of Health & Exercise Science, Appalachian State University, Boone, North Carolina.

Nina Stute (N)

Department of Health & Exercise Science, Appalachian State University, Boone, North Carolina.

Marc A Augenreich (MA)

Department of Health & Exercise Science, Appalachian State University, Boone, North Carolina.

Laurel K Koontz (LK)

Department of Health & Exercise Science, Appalachian State University, Boone, North Carolina.

Landry K Bobo (LK)

Department of Health & Exercise Science, Appalachian State University, Boone, North Carolina.

Abigail S L Stickford (ASL)

Department of Health & Exercise Science, Appalachian State University, Boone, North Carolina.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH